Compounded Tirzepatide dosing schedule
Compounded Tirzepatide dosing follows a step-up titration designed to minimize the gastrointestinal side effects that are common with GLP-1 medications. Starting at the lowest dose, the prescriber increases gradually — typically every 4 weeks — until the target therapeutic dose is reached. This page details the FDA-labeled schedule, what to do if you miss a dose, and the maximum approved dose.
Compounded Tirzepatide dose titration
Class-typical schedule. Your prescriber may individualize the schedule based on tolerance and goals.
Week 1–4
2.5 mg
Starting dose — body adjusts
Week 5–8
5 mg
First therapeutic dose
Week 9+
7.5–15 mg
Titrate by 2.5 mg every 4 weeks as tolerated
Maintenance
Up to 15 mg
Maximum approved dose
Why titration matters
Starting at the target dose causes severe nausea, vomiting, and dropout for most patients. Titration lets the gut adapt: the GLP-1 receptors gradually adjust to the new signaling, gastric emptying slows in tolerable increments, and your appetite signal recalibrates over weeks. Studies show titration improves both tolerability and long-term adherence.
The full titration schedule
Per FDA labeling for Compounded Tirzepatide, the standard titration is:
- Week 1–4: 2.5 mg — Starting dose — body adjusts
- Week 5–8: 5 mg — First therapeutic dose
- Week 9+: 7.5–15 mg — Titrate by 2.5 mg every 4 weeks as tolerated
- Maintenance: Up to 15 mg — Maximum approved dose
How to inject Compounded Tirzepatide
Compounded Tirzepatide is a subcutaneous injection — under the skin, not into muscle or vein. Common injection sites: abdomen (at least 2 inches from belly button), upper outer thigh, back of upper arm. Rotate sites with each dose to avoid skin reactions. The injection pen is pre-filled with the prescribed dose; turn the dial to confirm the right dose before injecting.
Storage requirements
Storage & timing for Compounded Tirzepatide
Practical handling guidance. Always follow the dispensed label.
Before use
36°F–46°F (2°C–8°C) in original carton until use
At room temperature
Up to 21 days at room temperature (≤86°F / 30°C)
After first use
Discard pen 21 days after first use
When to inject
Any time of day, with or without food. Same day each week.
If you miss a dose
Take within 4 days of missed dose; otherwise skip and resume schedule.
What if you miss a dose?
Take within 4 days of missed dose; otherwise skip and resume schedule.
Maximum dose
The highest FDA-approved dose for Compounded Tirzepatide is Up to 15 mg. Going above this dose hasn't been shown to add efficacy and substantially increases side effects. Prescribers occasionally maintain patients at a lower-than-maximum dose if it provides adequate effect with better tolerability.
Common dosing mistakes
- Injecting into muscle instead of fat — too deep injection alters absorption rate
- Reusing pens past the discard date — efficacy drops past the labeled shelf life after first use
- Skipping the priming step on pens that require it — under-doses the first injection
- Storing pens in the freezer — destroys the medication (refrigerator only, never freezer)
- Increasing dose too quickly — often results in severe nausea and treatment dropout
FAQ about Compounded Tirzepatide dosage
Can I stay at a lower dose long-term?
Yes — many patients maintain at a lower-than-maximum dose if it provides adequate weight loss / glycemic control with better tolerability. Your prescriber decides based on response.
What if I need to pause Compounded Tirzepatide for surgery?
Tell your prescribing physician and surgeon in advance. GLP-1s slow gastric emptying, which can complicate anesthesia (aspiration risk). Most surgeons recommend pausing the medication for a week or more before scheduled surgery.
How long until I see results at the starting dose?
Modest appetite reduction begins within 1-2 weeks. Significant weight loss usually requires reaching at least the second titration step. Full trial-equivalent results take 16-72 weeks depending on the medication.
Always follow your prescriber's specific dosing instructions over generic guides. Full medical disclaimer.